Related Experiment Video
Updated: Apr 11, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Explaining pharmacophobia and pharmacophilia in psychiatric patients: relationship with treatment adherence
Carlos De Las Cuevas1, Wenceslao Peñate2
1Department of Internal Medicine, Dermatology and Psychiatry, University of La Laguna, San Cristóbal de La Laguna, Canary Islands, Spain.
Objective:
The objective of this study is to assess psychiatric patient attitudes towards psychotropic medication and their association with adherence, as well as to identify the factors that influence these attitudes.
Methods:
Nine hundred and forty nine consecutive psychiatric outpatients categorized as "pharmacophobic" or "pharmacophilic" according to the Drug Attitude Inventory were compared with regard to adherence to prescribed treatment, socio-demographic variables, clinical characteristics, health locus of control, self-efficacy, and psychological reactance.
Results:
Seventy three per cent of psychiatric outpatients showed a "pharmacophilic" attitude and 15.5% "pharmacophobic" one. Patients' attitudes toward prescribed drug treatment were clearly related to self-reported treatment adherence. The pharmacophobic group registered significant worse adherence than the pharmacophilic patients. Psychiatric patients' attitudes to drugs were mediated by external health locus of control, cognitive psychological reactance, and self-efficacy.
Conclusion:
The encouragement of psychiatric patients' treatment adherence needs to include lack of coercion during prescription, a positive relationship with the prescriber, verbal persuasion, information containing vicarious experience, and the involvement of the patient in treatment decisions.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Drug Abuse and Addiction: Pharmacological Phenomena
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Psychosis and Antipsychotic Drugs: Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

